Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 20,000 shares at $62.47 ($1.2M) on 2020-04-16, disclosed to the SEC on 2020-04-20.
Seasonal sale ($1.2M) by Chairman — this insider has traded EBS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |